AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 66 min read$PUBM

PubMatic, Inc. (PUBM): Results of Operations and Financial Condition

PubMatic, Inc. (PUBM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226pressrelease.htm EX-99.1 Document EXHIBIT 99.1 PubMatic Announces Second Quarter 2026 Financial Results Delivered revenue and adjusted EBITDA well ahead of guidance; AI customer adoption more than doubled sequentially, delivering 80+ agentic campaigns and 4,000+ AI-

Original reporting
SEC EDGAR 8-K
Published Aug 6, 2026, 8:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$PUBM
Bullish
medium confidence
Mentioned
$PUBM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PUBMBullishMed
01

Why it matters

The newest disclosed facts are the quarter’s financial beats versus guidance, the magnitude of free cash flow improvement, and operational KPIs tied to AgenticOS and AI-powered deals, alongside a share repurchase update.

02

Market read

A beat on revenue, adjusted EBITDA, and free cash flow plus accelerating AI campaign/deal activity can shift expectations for growth and margins, making the filing relevant for near-term positioning.

03

What to watch

Buyback activity is highlighted, but traders may also want to scrutinize cash flow quality, any changes in revenue mix (CTV/mobile/emerging), and whether the AI-native platform economics can scale without margin dilution.

Relevance 7/10Novelty 8/10Timing: after-hours SEC filing and earnings release dated Aug 6, 2026

Background

The filing is an SEC Form 8-K with an attached press release covering PubMatic’s Q2 2026 results and officer-related item 5.02.

Company-level read

Ticker impact

$PUBMBullishMedium confidence
Context

PubMatic reported Q2 2026 revenue of $78.6M (+11% YoY) and adjusted EBITDA of $19.6M (+38% YoY) ahead of guidance, plus 47% higher free cash flow.

Expected impact

Bullish bias for the next few sessions as traders digest beat metrics, AI campaign/deal momentum, and capital return; follow-through depends on whether the market believes the inflection is sustainable.

Evidence & confidence

This is a primary SEC filing with quantified results (revenue, adjusted EBITDA, FCF), plus operational KPIs (80+ autonomous campaigns, 4,000+ AI-powered deals) and a stated expectation of continued double-digit growth and margin expansion.

Market effects

Sector

Signals improving profitability and AI-driven performance advertising adoption in ad tech, potentially supporting sentiment for other programmatic/AI ad-tech names.

Regional

Limited direct regional read-through; mostly US-listed company-specific results.

Global

Mentions global campaign execution and partnerships, but the disclosed impact is primarily company-specific.

Counterpoint

What could challenge this read

The article emphasizes AI adoption and performance gains, but it does not provide forward guidance numbers or detailed customer concentration/retention metrics, leaving sustainability risk.

Key entities

  • company
    PubMatic, Inc.

    AI-powered ad tech company reporting Q2 2026 results and operational progress on AgenticOS and AI-native solutions.

  • executive
    Rajeev Goel

    Co-founder and CEO quoted on the quarter’s inflection and AI adoption.

  • executive
    Steve Pantelick

    CFO quoted on beating guidance and expectations for continued growth and margin expansion.

Read at source← All news

Related articles

AUG 7
$TEAMHighAI 8/10

Five earnings winners lead Friday’s premarket surge

Atlassian (TEAM) surged about 31% premarket after fiscal Q4 adjusted EPS of $1.87 vs $1.50 consensus and revenue of $1.77B vs $1.66B, with cloud revenue up 31% and remaining performance obligations up 44%, plus a GAAP operating profit. Other premarket gainers: Doximity (+66%), Cloudflare (+16.2%), PubMatic (+30.4%), FIGS (+28-30%).

investing.com6 min
AUG 7
$DOCSHighAI 8/10

Doximity, Cloudflare and Atlassian surge premarket

U.S. stock index futures edged higher ahead of the monthly jobs report, with investors watching the Federal Reserve rate outlook. Premarket movers included Doximity (+66%) on fiscal Q1 beats and raised targets, Atlassian (+31%) on a Q4 earnings beat, and Cloudflare (+16%) after raising 2026 revenue guidance. The Trade Desk fell more than 27% on weak outlook.

investing.com4 min
AUG 7
$PUBMHighAI 9/10

Why is PubMatic stock up 30% today?

PubMatic shares rose about 30% in pre-open after the company reported Q2 2026 results above expectations. Revenue was $78.6M, up 11% YoY. Adjusted EPS was $0.12 versus a consensus loss of $0.23, and adjusted EBITDA rose 38% to $19.6M with a 25% margin. Q3 revenue guidance was $75–$77M. Multiple analyst upgrades and buybacks were cited.

investing.com4 min
AUG 2
$PUBMMed

Magnite CEO warns of far fewer SSPs as PubMatic faces a $70m quarter

Magnite CEO Michael Barrett said sell-side platform (SSP) consolidation is likely, with fewer, more technically sophisticated SSPs surviving, and that agentic ad spend forecasts for 2027 top around $600m to $700m, still in discovery. The article contrasts this with PubMatic’s agentic product launches and Q1 2026 results: $62.6m revenue, $12.5m GAAP net loss, $2.6m adjusted EBITDA, and emerging revenues up 80% to $8.8m. PubMatic reports Aug 6.

ppc.land7 min
AUG 8
$DRIMedAI 8/10

DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) reported Q2 2026 results for the quarter ended June 30, 2026: total income $50.1M, total cash receipts $46.5M, and adjusted EBITDA $42.6M. It repurchased 89,513 units at $11.65 and paid a $0.11/unit distribution. After quarter-end, it exercised a put option on Ekterly for about $178M and received FDA approval for Lumvoa (veligrotug), triggering $75M milestone payments.

newswire.ca6 min